Protocol Design White Papers & Case Studies
-
Oesophageal Cancer: Global Clinical Trial Landscape (2024)
8/19/2024
Oesophageal cancer is the 11th most common cancer and the 7th leading cause of cancer deaths, starting in the esophagus. Explore our report to discover the latest in treatments, clinical trials, and future innovations.
-
Novel Platform For Execution Of Pragmatic Studies Boosts Cancer Trial Efficiency
8/19/2024
Learn how Flatiron partnered with Genentech and Foundation Medicine to develop a novel platform for the execution of pragmatic studies.
-
Outlook Good For 7 Drugs Up For Q3 Review
8/15/2024
A total of 24 drugs, devices, diagnostics, and deals are expected to progress in the third quarter of 2024, including approval applications for 17 drugs. The estimated overall likelihood of approval is 90% or higher for seven of those drugs, including revumenib for acute myelogenous leukemia and KarXT for schizophrenia.
-
Cell And Gene Therapy Field Quiet In Q2
8/15/2024
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.
-
Technology And Scientific Expertise To Power Your Program
8/5/2024
Learn how our expertise in eCOA, RTSM, and eConsent solutions can accelerate your drug development program from early phases to regulatory approval.
-
Improving Patient Health And Safety: Medical Affairs
8/2/2024
A medical affairs department needed leaders with scientific and project management expertise. With no time for training or risk tolerance, a consultant was hired to align activities with development and launch plans.
-
Clinical Trial Site Selection And Management
7/25/2024
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
-
Case Study: How Real-World Data Optimized An Oncology Clinical Trial Protocol
7/23/2024
Many challenges in running clinical trials are difficult to prepare for, but some, such as trial enrollment and study operational execution, can be proactively addressed thanks to advances in high-quality RWD.
-
New Is Risky. Start With A Free Feasibility Report.
7/23/2024
Get a free preliminary evaluation of your protocol design from a leading CRO in Eastern Europe.
-
How To Avoid Costly Study Delays And Mitigate Risks
7/22/2024
Are you still in doubt about your study protocol or how to determine the sample size? Gain access to free clinical trial budgeting and MedSci consulting services from a leading Eastern European CRO.